Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Edwards

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Pharmacology Research & Perspectives|January 21, 2020
Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitorYu Cai, Jun Yu, Ping Ren, et al.
Journal of Medicinal Chemistry|April 30, 2019
Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual InhibitorsHong Jia, Guangxiu Dai, Weiguo Su, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-onesRobert I Higuchi, Anthony W Thompson, Jyun-Hung Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Journal of Medicinal Chemistry|July 19, 2021
Discovery of Highly Potent and Selective IRAK1 Degraders to Probe Scaffolding Functions of IRAK1 in ABC DLBCLLiqiang Fu, Jing Zhang, Bin Shen, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1Alice Lee-Dutra, Danielle K Wiener, Kristen L Arienti, et al.
Journal of Medicinal Chemistry|September 5, 2003
The first potent and selective non-imidazole human histamine H4 receptor antagonistsJill A Jablonowski, Cheryl A Grice, Wenying Chai, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2017
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγtDavid A Kummer, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Pharmacology Research & Perspectives|January 21, 2020
Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitorYu Cai, Jun Yu, Ping Ren, et al.
Journal of Medicinal Chemistry|April 30, 2019
Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual InhibitorsHong Jia, Guangxiu Dai, Weiguo Su, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-onesRobert I Higuchi, Anthony W Thompson, Jyun-Hung Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Journal of Medicinal Chemistry|July 19, 2021
Discovery of Highly Potent and Selective IRAK1 Degraders to Probe Scaffolding Functions of IRAK1 in ABC DLBCLLiqiang Fu, Jing Zhang, Bin Shen, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1Alice Lee-Dutra, Danielle K Wiener, Kristen L Arienti, et al.
Journal of Medicinal Chemistry|September 5, 2003
The first potent and selective non-imidazole human histamine H4 receptor antagonistsJill A Jablonowski, Cheryl A Grice, Wenying Chai, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2017
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγtDavid A Kummer, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Pageof 8